Skip to content

Moving Closer to Affordable Advanced Therapies: A Review of Current Trends in Downstream Processing

By M T

Originally published in International Biopharmaceutical Industry Journal, Volume 7, Issue 4. Tozaro’s Head of Cell and Gene Therapy Applications, Abdullah Sufan, discusses the latest trends shaping downstream processing and the technologies helping to make advanced therapies more affordable and scalable. This review explores the evolving landscape of viral vector purification, highlighting emerging approaches that can … Continued

Behind the Batch Episode 2 – Giuliana Vallanti

By M T

Behind the Batch spotlights the moments that shape the people pioneering cell and gene therapy. Failed batches, first viable runs, tech transfers, and everything in between. In episode 2, our host Alex Shephard chats with Giuliana Vallanti, SVP Operations and R&D at AGC Biologics. She discusses two decades in cell and gene therapy, from process … Continued

Rewriting Bioprocessing with Synthetic Affinity Ligands – Presented at Bioprocessing Summit 2026

By M T

First presented at The Bioprocessing Summit 2026, this poster introduces a platform of synthetic Smart PolymersTM, rationally designed as affinity ligands for the selective capture, release, and purification of AAV and lentiviral vectors. These reagents are engineered to enable serotype-specific or pan-serotype binding, with tunable affinity for both purification and analytical use.

Behind the Batch Episode 1 – Andre Raposo

By M T

Behind the Batch spotlights the moments that shape the people pioneering cell and gene therapy. Failed batches, first viable runs, tech transfers, and everything in between. In episode 1, our host Alex Shephard chats with Andre Raposo, Senior Director of Innovation about his journey from fundamental HIV research to leading innovation in viral vector manufacturing … Continued

Tozaro Limited raises £6m/$8.2m to accelerate development & commercialization of Smart Polymer™ affinity ligands in cell & gene therapy

By M T

BEDFORD, UK, 16th February 2026 / Tozaro Limited, a company leveraging molecular modelling and ML to design and develop stable, cost-effective, specific and selective polymer-based ligands, announces a £6m/$8.2m funding round. The investment was led by Mercia Ventures, which was investing from the Midlands Engine Investment Fund II and from its own funds, alongside other … Continued

Tozaro secures Canada-UK Research & Development funding todevelop tools for lentiviral production, in partnership with ViricaBiotech Inc. and Centre for Process Innovation (CPI)

By M T

Bedfordshire, UK, 17 September 2025: Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, is pleased to announce today that it has been awarded £154,000 in funding as part of a consortium developing novel tools to improve lentiviral vector manufacturing. The consortium includes Virica (supported through the National Research Council … Continued